Coreg (carvedilol) for heart failure, post-heart attack LV dysfunction, and hypertension

Coreg (carvedilol) is a medication used to treat mild to severe chronic heart failure, manage left ventricular dysfunction after a heart attack, and control essential hypertension. It is typically used alongside other heart medications to improve survival, reduce hospitalizations, and lower the risk of death from heart-related causes.

• Chronic heart failure: For mild to severe cases originating from ischemic or cardiomyopathic causes. Usually given with diuretics, ACE inhibitors, and digitalis to improve survival and reduce hospital admissions.
• Left ventricular dysfunction after myocardial infarction: To reduce cardiovascular mortality in clinically stable patients with left ventricular ejection fraction ≤40%, with or without symptoms of heart failure.
• Essential hypertension: For blood pressure management either alone or combined with other antihypertensive drugs, especially thiazide-type diuretics.

carvedilol

Coreg blocks both alpha and beta adrenergic receptors, which helps lower heart rate and blood pressure, reduces heart workload, and dilates blood vessels. This combined action improves heart function and reduces the risks associated with heart failure, heart attack-related dysfunction, and high blood pressure.

General advice

Coreg must be taken with food to slow absorption and reduce the chance of dizziness or fainting from low blood pressure. Dosage should be individualized and carefully monitored, especially during dose increases.

For chronic heart failure

• Start at 3.125 mg twice daily for 2 weeks.
• If tolerated, increase gradually every 2+ weeks to 6.25 mg, 12.5 mg, then 25 mg twice daily.
• Maximum dose up to 50 mg twice daily can be used for patients over 85 kg if tolerated.

For left ventricular dysfunction after myocardial infarction

• Start at 6.25 mg twice daily.
• Increase after 3 to 10 days to 12.5 mg, then to 25 mg twice daily if tolerated.
• Lower starting doses or slower dose increases may be used for certain patients based on tolerance.

For hypertension

• Start at 6.25 mg twice daily.
• If needed for blood pressure control, increase every 1 to 2 weeks to 12.5 mg, then 25 mg twice daily.
• Total daily dose should not exceed 50 mg.

Dosing considerations

• Fluid retention should be minimized before starting Coreg and managed with diuretics during therapy.
• Dose reduction is recommended if heart rate falls below 55 beats per minute.
• Patients may experience dizziness or lightheadedness after starting or increasing doses; avoid driving or hazardous activities initially.
• Not recommended for patients with severe hepatic impairment.

• Bronchial asthma or related bronchospastic conditions due to risk of fatal asthma attacks.
• Second- or third-degree atrioventricular (AV) block.
• Sick sinus syndrome.
• Severe bradycardia (unless patient has a permanent pacemaker).
• Cardiogenic shock or decompensated heart failure requiring intravenous inotropic therapy.
• Severe hepatic impairment.
• History of serious hypersensitivity reactions to carvedilol or any component of the medication.

Serious warnings and precautions:

• Abrupt discontinuation: Stopping Coreg suddenly can cause severe worsening of angina, heart attacks, or dangerous heart rhythms. It should be stopped gradually over 1-2 weeks under medical supervision.
• Bradycardia (slow heart rate): Occurs in some patients; reduce dose if pulse drops below 55 bpm.
• Hypotension (low blood pressure): May cause dizziness, syncope, especially in first 30 days; start at low dose and titrate slowly.
• Worsening heart failure/fluid retention: May worsen during dose increases; requires diuretic adjustment and careful monitoring.
• Bronchospastic disease: Generally avoid in patients with asthma or related conditions. Use cautiously in chronic bronchitis or emphysema at lowest effective dose.
• Diabetes: Can mask hypoglycemia symptoms and worsen blood sugar control; monitor glucose closely.
• Peripheral vascular disease: Can worsen arterial insufficiency; use with caution.
• Renal function deterioration: Rare worsening kidney function can occur; monitor kidney function especially in at-risk patients.
• Anesthesia: Use caution with anesthetic agents that depress heart function if continuing Coreg perioperatively.
• Thyroid disease: Beta-blockade may mask hyperthyroidism symptoms; abrupt withdrawal can precipitate thyroid storm.
• Pheochromocytoma and Prinzmetal’s angina: Use with caution due to lacking clinical experience.
• Allergic reactions: May increase severity of anaphylaxis and reduce response to epinephrine.

Common side effects:

• Dizziness or lightheadedness, especially after initial dose or dose increases.
• Bradycardia (slow heart rate).
• Hypotension and postural hypotension, which may sometimes cause syncope.
• Fluid retention or worsening heart failure symptoms during dose escalation.

Serious side effects leading to discontinuation occur infrequently but include:

• Severe hypotension and syncope.
• Worsening heart failure symptoms.

• Concomitant use with diuretics may increase additive blood pressure lowering and risk of orthostatic hypotension.
• Use caution with ACE inhibitors; separating dosing times or reducing ACE inhibitor dose temporarily may help vasodilatory symptoms.